Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study

BACKGROUND: Chemotherapy is the major choice for advanced non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor exon 20 insertion (EGFR ex20ins). The efficacy of pemetrexed-based with other chemotherapy regimens and EGFR ex20ins subtypes in this population has not been we...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Chun-Wei, Wang, Wen-Xian, Wang, Dong, Wang, Qi-Ming, Pu, Xing-Xiang, Zhu, You-Cai, Huang, Jian-Hui, Yu, Zong-Yang, Cui, Zhao-Lei, Chen, Xiao-Hui, Li, Jin-Luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Lan, Shi-Jie, Cai, Xin, Zhang, Yin-Bin, Gao, Wen-Bin, Wang, Li-Ping, She, Ke-Lin, Rao, Chuang-Zhou, Zhou, Yue-Fen, Fang, Mei-Yu, Miao, Li-Yun, Lei, Lei, Lv, Tang-Feng, Song, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653161/
https://www.ncbi.nlm.nih.gov/pubmed/33209607
http://dx.doi.org/10.21037/tlcr-20-382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653161/
https://www.ncbi.nlm.nih.gov/pubmed/33209607
http://dx.doi.org/10.21037/tlcr-20-382

Ejemplares similares